Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$29,206,549
+$1,061,972 QoQ
Shares Held
115,000
-0.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.04%
of 13F equity value
Holder Rank
#600
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity & Verity, LLC holds $179,692,626 across 7 Drug Manufacturers - General names. JNJ ranks #5 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
178,972 | $45,036,514 | |
| 2 | AMGN |
Amgen Inc
|
104,299 | $37,768,753 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
272,652 | $34,446,853 | |
| 4 | PFE |
Pfizer Inc
|
1,338,533 | $32,231,874 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
115,000 | $29,206,549 | |
| 6 | NVS |
Novartis AG
|
3,453 | $541,154 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,587 | $460,929 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,206,549 | 115,000 | Shares | Other | 2026-07-28 | |
| 2026-03-31 | $28,144,577 | 115,139 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $24,149,615 | 116,693 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $21,309,022 | 114,923 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $17,334,375 | 113,482 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $18,822,176 | 113,496 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $15,342,012 | 106,085 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $15,563,432 | 96,035 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $13,041,418 | 89,227 | Shares | Sole | 2024-09-16 | |
| 2024-03-31 | $13,002,427 | 82,195 | Shares | Sole | 2024-09-16 | |
| 2023-12-31 | $14,216,631 | 90,702 | Shares | Sole | 2024-11-07 | |
| 2023-09-30 | $13,853,028 | 88,944 | Shares | Sole | 2024-11-07 | |
| 2023-06-30 | $14,378,225 | 86,867 | Shares | Sole | 2024-11-07 | |
| 2023-03-31 | $13,036,895 | 84,109 | Shares | Sole | 2024-11-07 | |
| 2022-12-31 | $14,095,256 | 79,792 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $12,188,452 | 74,611 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $12,674,391 | 71,401 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $12,594,318 | 71,062 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $11,595,808 | 67,784 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $10,692,107 | 66,205 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $10,641,380 | 64,595 | Shares | Sole | 2021-09-20 | |
| 2021-03-31 | $10,604,355 | 64,523 | Shares | Sole | 2021-06-21 | |
| 2020-12-31 | $9,310,443 | 59,159 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $7,930,390 | 53,267 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $7,230,210 | 51,413 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $6,541,551 | 49,886 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||